| scholarly article | Q13442814 |
| P356 | DOI | 10.1254/JJP.87.143 |
| P698 | PubMed publication ID | 11700013 |
| P2093 | author name string | Suzuki M | |
| Matsuura A | |||
| Sato T | |||
| Sato K | |||
| Hiraide A | |||
| Dohi S | |||
| P433 | issue | 2 | |
| P921 | main subject | hypoxia | Q105688 |
| cerebral hypoxia | Q2249526 | ||
| P304 | page(s) | 143-150 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Journal of Pharmacological Sciences | Q15766064 |
| P1476 | title | Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats | |
| P478 | volume | 87 |
| Q27347253 | 1H-NMR metabolomic biomarkers of poor outcome after hemorrhagic shock are absent in hibernators |
| Q41990257 | A ketogenic diet may offer neuroprotection in glaucoma and mitochondrial diseases of the optic nerve |
| Q99585183 | Adenosine and Ketogenic Treatments |
| Q41331414 | Beta-hydroxybutyrate, an endogenic NLRP3 inflammasome inhibitor, attenuates stress-induced behavioral and inflammatory responses |
| Q37959092 | Cerebral ketone metabolism during development and injury |
| Q33802454 | Cerebral metabolic adaptation and ketone metabolism after brain injury. |
| Q90706295 | Cholesterol Prevents Hypoxia-Induced Hypoglycemia by Regulation of a Metabolic Ketogenic Shift |
| Q37864740 | Clinical review: ketones and brain injury |
| Q92138482 | Comparison of engineered Escherichia coli AF1000 and BL21 strains for (R)-3-hydroxybutyrate production in fed-batch cultivation |
| Q43256162 | D-beta-hydroxybutyrate prevents MPP+-induced neurotoxicity in PC12 cells |
| Q48364448 | D-beta-hydroxybutyrate prevents glutamate-mediated lipoperoxidation and neuronal damage elicited during glycolysis inhibition in vivo |
| Q48109963 | Emergency preservation and resuscitation with profound hypothermia, oxygen, and glucose allows reliable neurological recovery after 3 h of cardiac arrest from rapid exsanguination in dogs |
| Q40558325 | Energy dysfunction as a predictor of outcome after moderate or severe head injury: indices of oxygen, glucose, and lactate metabolism |
| Q44675700 | Glutamate uptake inhibitor L-trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production |
| Q37409435 | Hitting a moving target: Basic mechanisms of recovery from acquired developmental brain injury. |
| Q21262020 | Hypometabolism as a therapeutic target in Alzheimer's disease |
| Q38860249 | Increasing the production of (R)-3-hydroxybutyrate in recombinant Escherichia coli by improved cofactor supply |
| Q46382531 | Influence of ketone bodies on oxidative stress parameters in brain of developing rats in vitro. |
| Q45802219 | Is on-admission capillary blood beta-hydroxybutyrate concentration associated with the acute stroke severity and short-term functional outcome? |
| Q36188715 | KTX 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders. |
| Q34206876 | Ketoacids? Good medicine? |
| Q55089719 | Ketogenic Diet Improves Brain Ischemic Tolerance and Inhibits NLRP3 Inflammasome Activation by Preventing Drp1-Mediated Mitochondrial Fission and Endoplasmic Reticulum Stress. |
| Q81271292 | Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration |
| Q36196765 | Ketogenic diets, mitochondria, and neurological diseases |
| Q42510499 | Ketone bodies are protective against oxidative stress in neocortical neurons |
| Q34795761 | Ketone bodies as a therapeutic for Alzheimer's disease |
| Q48233909 | Ketone bodies metabolism during ischemic and reperfusion brain injuries following bilateral occlusion of common carotid arteries in rats |
| Q36166231 | Ketone bodies protection against HIV-1 Tat-induced neurotoxicity |
| Q92572660 | Ketone bodies, stress response, and redox homeostasis |
| Q42085329 | Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation |
| Q42177440 | Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors |
| Q89983807 | Low-carbohydrate-diet scores and the risk of primary open-angle glaucoma: data from three US cohorts |
| Q39101800 | Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments |
| Q64941411 | Metabolomics for the early detection of cisplatin-induced nephrotoxicity. |
| Q90462018 | Modulation of Cellular Biochemistry, Epigenetics and Metabolomics by Ketone Bodies. Implications of the Ketogenic Diet in the Physiology of the Organism and Pathological States |
| Q88646795 | NMR metabolomic study of blood plasma in ischemic and ischemically preconditioned rats: an increased level of ketone bodies and decreased content of glycolytic products 24 h after global cerebral ischemia |
| Q38745984 | Neuroketotherapeutics: A modern review of a century-old therapy |
| Q34280603 | Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat--possible involvement of kynurenic acid |
| Q43120302 | Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity |
| Q24646914 | Neuroprotective and disease-modifying effects of the ketogenic diet |
| Q35679741 | Potential for discovery of neuroprotective factors in serum and tissue from hibernating species |
| Q35572816 | Protection of hypoglycemia-induced neuronal death by β-hydroxybutyrate involves the preservation of energy levels and decreased production of reactive oxygen species |
| Q35624347 | Purines and neuronal excitability: links to the ketogenic diet |
| Q28073224 | Regulation of Ketone Body Metabolism and the Role of PPARα |
| Q61817166 | Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease) |
| Q33460503 | Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease |
| Q27023207 | Stroke outcome in the ketogenic state--a systematic review of the animal data |
| Q21245063 | Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial |
| Q26769966 | The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis |
| Q61446576 | The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome |
| Q33744257 | The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat. |
| Q24646616 | The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies |
| Q47902341 | The protective effect of the ketogenic diet on traumatic brain injury-induced cell death in juvenile rats |
| Q46289935 | The therapeutic potential of a calorie-restricted ketogenic diet for the management of Leber hereditary optic neuropathy |
Search more.